Guoping Da, an IP litigator and counselor, represents multinational companies in cross-border IP enforcement and infringement actions. These representations have involved a broad range of technologies such as biotechnology, pharmaceuticals, animal health products, optics, semiconductors, and consumer electronics. Guoping also has extensive experience in the area of trade secrets, and she published an article regarding strategies for trade secret protection.
Guoping is experienced in assisting clients in technology transfer transactions involving significant assets, including Incyte (small molecule drugs and biologics), Huadong Medicine (medicial devices and AI technology), LeaderMed (biologics), and Zhongze Therapeutics (biologics).
Guoping also assists multinational companies on compliance and corruption matters. Her experience includes advising clients on Foreign Corrupt Practices Act (FCPA) issues and conducting related investigations, providing compliance training for clients operating in China, and conducting anticorruption due diligence for inbound investment.
Guoping's Ph.D. thesis focused on structure determination and function characterization of gene regulatory proteins, including histone deacetylases and histone demethylases. As such, she is familiar with a broad range of molecular, biochemical, and biophysical research tools centered around X-ray crystallography and structure-based drug design.
- January 18, 2016
Fee Shifting Strategies for Patent Troll Litigation and IP Review in M&A Transactions
- Baylor University (J.D. magna cum laude 2009; Technical Editor, Senior Notes and Comments Editor, Baylor Law Review); University of Pennsylvania (Ph.D. in Biochemistry 2006); Beijing University (B.S. in Chemistry 2000)
- Texas and U.S. District Courts for the Eastern and Northern Districts of Texas
- Mandarin and English